Free Trial

Ashtead Group (AHT) Competitors

Ashtead Group logo
GBX 5,328 +26.00 (+0.49%)
As of 08/15/2025 11:51 AM Eastern

AHT vs. BXP, LSE, WPY, LAND, TW, SIR, SAFE, CLIN, EVR, and BGSC

Should you be buying Ashtead Group stock or one of its competitors? The main competitors of Ashtead Group include Beximco Pharmaceuticals (BXP), London Stock Exchange Group plc (LSE.L) (LSE), Worldpay (WPY), Land Securities Group (LAND), Taylor Wimpey (TW), Secure Income REIT (SIR), Safestore (SAFE), Clinigen Group (CLIN), EVRAZ (EVR), and BMO Global Smaller Companies (BGSC). These companies are all part of the "trading" industry.

Ashtead Group vs. Its Competitors

Ashtead Group (LON:AHT) and Beximco Pharmaceuticals (LON:BXP) are both large-cap trading companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, earnings, valuation, institutional ownership, risk, profitability and analyst recommendations.

66.7% of Ashtead Group shares are owned by institutional investors. Comparatively, 1.7% of Beximco Pharmaceuticals shares are owned by institutional investors. 0.6% of Ashtead Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Beximco Pharmaceuticals has higher revenue and earnings than Ashtead Group. Beximco Pharmaceuticals is trading at a lower price-to-earnings ratio than Ashtead Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ashtead Group£13.67B2.13£1.93B£280.9918.96
Beximco Pharmaceuticals£7.08T0.00£970.84B£9.325.05

In the previous week, Ashtead Group had 2 more articles in the media than Beximco Pharmaceuticals. MarketBeat recorded 3 mentions for Ashtead Group and 1 mentions for Beximco Pharmaceuticals. Ashtead Group's average media sentiment score of 0.39 beat Beximco Pharmaceuticals' score of 0.20 indicating that Ashtead Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ashtead Group
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Beximco Pharmaceuticals
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Ashtead Group has a net margin of 14.08% compared to Beximco Pharmaceuticals' net margin of 13.71%. Ashtead Group's return on equity of 21.43% beat Beximco Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Ashtead Group14.08% 21.43% 7.78%
Beximco Pharmaceuticals 13.71%13.12%6.97%

Ashtead Group currently has a consensus target price of GBX 6,120.83, indicating a potential upside of 14.88%. Given Ashtead Group's stronger consensus rating and higher possible upside, analysts plainly believe Ashtead Group is more favorable than Beximco Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ashtead Group
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67
Beximco Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Ashtead Group pays an annual dividend of GBX 80 per share and has a dividend yield of 1.5%. Beximco Pharmaceuticals pays an annual dividend of GBX 3 per share and has a dividend yield of 6.4%. Ashtead Group pays out 28.5% of its earnings in the form of a dividend. Beximco Pharmaceuticals pays out 32.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Ashtead Group has a beta of 1.22, suggesting that its stock price is 22% more volatile than the S&P 500. Comparatively, Beximco Pharmaceuticals has a beta of 0.61, suggesting that its stock price is 39% less volatile than the S&P 500.

Summary

Ashtead Group beats Beximco Pharmaceuticals on 15 of the 18 factors compared between the two stocks.

Get Ashtead Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for AHT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AHT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AHT vs. The Competition

MetricAshtead GroupRental & Leasing Services IndustryIndustrials SectorLON Exchange
Market Cap£29.09B£3.19B£7.62B£3.09B
Dividend Yield0.02%5.60%4.56%5.04%
P/E Ratio18.9618.5825.93174.60
Price / Sales2.1364.14101.30282,733.39
Price / Cash820.97107.2628.3927.94
Price / Book3.121.684.325.38
Net Income£1.93B£240.18M£797.05M£5.89B
7 Day Performance5.25%0.07%3.06%-0.13%
1 Month Performance13.87%-0.32%1.75%1.01%
1 Year Performance2.26%12.48%32.36%64.41%

Ashtead Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AHT
Ashtead Group
2.2134 of 5 stars
GBX 5,328
+0.5%
GBX 6,120.83
+14.9%
+0.4%£29.09B£13.67B18.96120News Coverage
Dividend Cut
Analyst Forecast
BXP
Beximco Pharmaceuticals
N/AGBX 45
+3.4%
N/A+36.6%£30.68B£7.08T4.835,500Gap Up
LSE
London Stock Exchange Group plc (LSE.L)
N/AN/AN/AN/A£30.31B£2.41B76.694,965
WPY
Worldpay
N/AN/AN/AN/A£29.39B£4.04B194.44190
LAND
Land Securities Group
2.3328 of 5 stars
GBX 583
-0.6%
GBX 671
+15.1%
-8.9%£4.32B£823.49M-13.52598
TW
Taylor Wimpey
4.496 of 5 stars
GBX 101.50
-0.3%
GBX 143.17
+41.1%
-38.6%£3.65B£3.45B14.811,090High Trading Volume
SIR
Secure Income REIT
N/AN/AN/AN/A£1.49B£122.40M743.55N/A
SAFE
Safestore
4.1065 of 5 stars
GBX 663
-2.2%
GBX 820
+23.7%
-23.0%£1.44B£222.85M5.46120Positive News
CLIN
Clinigen Group
N/AN/AN/AN/A£1.23B£565.60M64.691,000
EVR
EVRAZ
0.2852 of 5 stars
GBX 81
flat
N/AN/A£1.18B£15.40B42.1971,591
BGSC
BMO Global Smaller Companies
N/AN/AN/AN/A£769.56M£303.85M2.77N/A

Related Companies and Tools


This page (LON:AHT) was last updated on 8/16/2025 by MarketBeat.com Staff
From Our Partners